In this edition of “Rising High,” The Fly conducted an exclusive interview with Peter Rands, chief executive officer of Small Pharma (DMTTF), a neuropharmaceutical company leading the worldâs first clinical trial for DMT-assisted therapy to treat major depression. Here are some… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3409732/-Rising-High-Exclusive-talk-with-neuropharmaceutical-company-Small-Pharma)
previous post